Aclarion Inc (ACON)
0.2823
-0.01
(-1.81%)
USD |
NASDAQ |
Jun 21, 16:00
0.283
0.00 (0.00%)
Pre-Market: 08:24
Aclarion Research and Development Expense (Quarterly): 0.239M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.239M |
| December 31, 2023 | 0.2207M |
| September 30, 2023 | 0.1983M |
| June 30, 2023 | 0.25M |
| March 31, 2023 | 0.2044M |
| December 31, 2022 | 0.219M |
| September 30, 2022 | 0.291M |
| Date | Value |
|---|---|
| June 30, 2022 | 0.3532M |
| March 31, 2022 | 0.2048M |
| December 31, 2021 | 0.1821M |
| September 30, 2021 | 0.2753M |
| June 30, 2021 | 0.1627M |
| March 31, 2021 | 0.1678M |
| December 31, 2020 | 0.1752M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.1627M
Minimum
Jun 2021
0.3532M
Maximum
Jun 2022
0.2245M
Average
0.2119M
Median
Research and Development Expense (Quarterly) Benchmarks
| Spok Holdings Inc | 2.951M |
| Ontrak Inc | 1.078M |
| DarioHealth Corp | 6.642M |
| National Research Corp | -- |
| FOXO Technologies Inc | -0.024M |